Drug recall D-0704-2017

Class III Terminated reported May 17, 2017

Product

Mozobil (plerixafor injection) 24mg/1.2mL (20mg/mL), For Single Use Only, Rx Only, Manufactured by: Genzyme Corporation 500 Kendall Street, Cambridge, MA 02412 USA NDC: 0024-5862-01

Reason for recall

Labeling: Incorrect or Missing Package Insert

Lots and codes

Lot #: 5RZ001C, 5RZ001D; Exp. 04/18

Recall details

Recalling firm
Sanofi-Aventis U.S. LLC, Bridgewater, NJ
Quantity
2133 vials
Distribution
Nattionwide
Type
Voluntary: Firm initiated
Recall initiated
September 1, 2016
Terminated
February 15, 2018

Related products